Log in

Customer case studies & Testimonials

Featured case study:
Brickell Biotech

Brickell Biotech manages their equity from private to public on Carta.

Andrew Booth, Chief Financial Officer, AbCellera Biologics 5

More featured case studies

Private company, SaaS

wattpad-logo-colored (1)

Wattpad

Canada-based Wattpad manages equity online with US investors

Venture capital

NLVC Logo

NLVC

How NLVC works with LPs in China and the US

Public companies, healthcare

Andrew Booth, Chief Financial Officer, AbCellera Biologics 6

Immunomedics

Immunomedics manages their equity through key milestones on Carta

Andrew Booth, Chief Financial Officer, AbCellera Biologics 7
Private Company
SaaS

How Calendly improved their 409A process by teaming up with Carta's in-house experts

Andrew Booth, Chief Financial Officer, AbCellera Biologics 8
Private company
Travel

How Day Trippers doubled their valuation after using Carta

Andrew Booth, Chief Financial Officer, AbCellera Biologics 9
Private company
Web3

How Gauntlet uses Carta Total Comp to hire competitively

Andrew Booth, Chief Financial Officer, AbCellera Biologics 10
Venture capital

How Harlem Capital invests in diversity

Andrew Booth, Chief Financial Officer, AbCellera Biologics 11
Venture capital

How High Circle Ventures used SPVs to launch a VC firm

Andrew Booth, Chief Financial Officer, AbCellera Biologics 12
Venture capital

How Kapor Capital uses Carta to advance its socially conscious investment thesis

Andrew Booth, Chief Financial Officer, AbCellera Biologics 13
Venture capital

How Las Olas uses Carta to manage their back office

Andrew Booth, Chief Financial Officer, AbCellera Biologics 14
Venture capital

How Carta enables better LP communication for M13's unique strategy

Andrew Booth, Chief Financial Officer, AbCellera Biologics 15
Venture capital

How CVCs can set themselves up for continued success

Andrew Booth, Chief Financial Officer, AbCellera Biologics 16
Private company
Saas, Finance

How PandaDoc uses Carta to streamline board consents

Andrew Booth, Chief Financial Officer, AbCellera Biologics 17
Private Company
SaaS

How Puppet switched to Carta for a modern, trusted platform

Andrew Booth, Chief Financial Officer, AbCellera Biologics 18
Venture capital

How to add unique value as a small VC fund

Andrew Booth, Chief Financial Officer, AbCellera Biologics 19
Private equity

How VCFA Group scaled their secondaries strategy

Andrew Booth, Chief Financial Officer, AbCellera Biologics 20
Private company
Saas

How VEERUM prepares for future business growth with Carta

Andrew Booth, Chief Financial Officer, AbCellera Biologics 21
Private equity

How Xenon Partners keeps startups' doors open

CUSTOMER TESTIMONIALS

What other customers are saying

Industry: Life Sciences Tools and Services

Public listing date: December 2020

Company overview: AbCellera Biologics develops antibody discovery platforms. Its full-stack, AI-powered drug discovery platform searches and analyzes the database of natural immune systems to find antibodies that can be developed as drugs. The Company was founded in 2012 and is headquartered in Vancouver, Canada.

Andrew Booth, Chief Financial Officer, AbCellera Biologics 1

“The [409A] report looked great to us, but more importantly, when we submitted it to the lawyers, underwriters, accountants, and everyone who would eventually pore over it, not once did we have to answer questions or go back and forth with our analyst to make changes – it was all there. This report was also completed under a very demanding timeline.”

Andrew Booth, Chief Financial Officer, AbCellera Biologics
abcellera

Industry: Automobile Manufacturers

Public listing date: October 2020

Company overview: Fisker focuses on design, development, manufacture, and sale of electric vehicles. The company was founded in 2016 and is headquartered in Manhattan Beach, California.

Andrew Booth, Chief Financial Officer, AbCellera Biologics 2

“The Carta team is amazing. Very efficient, knowledgeable and responsive.”

Dr. Geeta Gupta-Fisker, Co-Founder and Chief Financial Officer, Fisker
fisker

Industry: Pharmaceuticals

Public listing date: October 2020

Company overview: Tarsus Pharmaceuticals, a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutic candidates for ophthalmic conditions. The company was incorporated in 2016 and is headquartered in Irvine, California.

Andrew Booth, Chief Financial Officer, AbCellera Biologics 3

“The Carta valuation team was extremely helpful and professional in working with our Tarsus team as we prepared for our IPO; they were very responsive and proactive during this time with multiple calls to ensure alignment of valuation information with our finance team.”

Leo Greenstein, Chief Financial Officer, Tarsus Pharmaceuticals
tarsus

Industry: Biotechnology

Exit date: October 2020

Company overview: Spruce Biosciences, a biopharmaceutical company, focuses on developing and commercializing novel therapies for rare endocrine disorders. The company was incorporated in 2014 and is headquartered in Daly City, California.

Andrew Booth, Chief Financial Officer, AbCellera Biologics 4

“Carta played an important role in the work leading up to our initial public offering in 2020. The valuations were well prepared and aligned with expectations from all key stakeholders.”

Samir Gharib, Chief Financial Officer, Spruce Biosciences
spruce

Demo

Want to see how carta works?